https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Bellerophon_Therapeutics%2C_Inc.Bellerophon Therapeutics, Inc. - Revizia istoricului2026-04-17T22:07:48ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=Bellerophon_Therapeutics,_Inc.&diff=409813&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei Bellerophon Therapeutics, Inc. listata cu simbolul US.BLPH ==Descriere companie== Bellerophon Therapeutics, Inc. (www.bellerophon.com) is a clinical-stage therapeutics company. The Company is focused on developing the products that addresses unmet medical needs in the treatment of cardiopulmonary diseases. It is engaged in the development of nitric oxide therapy for patients with or at risk of pulmonary hypertension, or PH, using pulsatile nitric ox...2024-09-18T13:42:57Z<p>Pagină nouă: Pagina dedicata companiei Bellerophon Therapeutics, Inc. listata cu simbolul US.BLPH ==Descriere companie== Bellerophon Therapeutics, Inc. (www.bellerophon.com) is a clinical-stage therapeutics company. The Company is focused on developing the products that addresses unmet medical needs in the treatment of cardiopulmonary diseases. It is engaged in the development of nitric oxide therapy for patients with or at risk of pulmonary hypertension, or PH, using pulsatile nitric ox...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Bellerophon Therapeutics, Inc. listata cu simbolul US.BLPH<br />
<br />
==Descriere companie==<br />
Bellerophon Therapeutics, Inc. (www.bellerophon.com) is a clinical-stage therapeutics company. The Company is focused on developing the products that addresses unmet medical needs in the treatment of cardiopulmonary diseases. It is engaged in the development of nitric oxide therapy for patients with or at risk of pulmonary hypertension, or PH, using pulsatile nitric oxide delivery platform, INOpulse. INOpulse is a technology used in hospitals to deliver continuous flow of inhaled nitric oxide. Nitric oxide is naturally produced and released by the lining of the blood vessels and results in vascular smooth muscle relaxation, an important factor in regulating blood pressure. The Company is developing INOpulse for the treatment of patients with fibrotic interstitial lung disease (fILD) at a risk for pulmonary hypertension, which includes PH associated with idiopathic pulmonary fibrosis as well as other pulmonary fibrosing diseases. The Company completed Phase II clinical trial.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.BLPH" /><br />
<br />
==Ultimele stiri despre Bellerophon Therapeutics, Inc. (US.BLPH)==<br />
<dynamicpagelist><br />
category=US.BLPH<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.BLPH]][[Categorie:Stiri despre companii]]</div>Admin